May 22, 2024 Recently, our product and engineering team had the opportunity to attend the AWS Summit, an event that sheds light on the latest developments and advancements in cloud computing. As avid users of AWS for our platform, we were eager to discover what was new and on the horizon. If we had to summarise the summit in just two words, they would undoubtedly be "Artificial Intelligence" (AI). The AI Revolution Throughout the summit, more than 95% of the talks were dedicated to AI and its potential to revolutionise industries. We were captivated by discussions on how AI will reshape workflows, automate processes, and unlock unparalleled possibilities. However, alongside these opportunities, there are risks that need to be carefully navigated. With AI's growing influence, new roles and responsibilities will emerge, and organisations will need clear strategies and roadmaps to leverage its potential effectively. Crafting an AI Strategy One of the key takeaways from the AWS Summit was

May 01, 2024 Last month we attended the LogiPharma 2024, a major life sciences supply chain event that took place at the Centre de Congrès de Lyon, in France, to learn about the latest trends, challenges, and opportunities in the life sciences supply chain, as well as network with peers and explore innovative solutions. The event, which was well attended, covered topics such as sustainability initiatives, economic uncertainties, geopolitical risks, digital innovations, and drug/device innovations impacting the life sciences supply chain. To find out more, we talked to James Emslie, who recently joined the team as Enterprise Sales Manager. Q: James, you just joined us and already jet-setted off to your first event with Veratrak—how was it? And could you dish on some of the main challenges buzzing around the pharmaceutical industry today? James: It was quite the intro! Diving right into the deep end, but hey, that's how we learn to swim, right? Or at least avoid sinking in front of my ne

March 25, 2024 In a risk-averse sector like pharma, the conservative approach to implementing new technologies has resulted in a slower uptake of innovative digital solutions that could revolutionise supply chain management. Overcoming this inertia requires a shift towards embracing emerging technologies that can drive efficiency and competitiveness. In this article, we look at how embracing Supply Chain 4.0 can help build a future-ready and resilient pharma supply chain ecosystem. At its core, Supply Chain 4.0 embodies the digitalisation of supply chain processes through the seamless integration of advanced technologies such as AI and IoT into the manufacturing process. It has created a disruption and requires companies to rethink the way they design their supply chain. However, as we know, the pharma industry has historically been cautious in adopting new technologies due to regulatory constraints and a focus on product development over operational optimisation. According to a study

February 19, 2024 The global supply chain has connected customers with drug product manufacturers and patients in need across the world, however the Biotech and Pharma industry is a significant contributor to global climate change, and therefore must accelerate their path to net zero. While the industry is supportive of the 2015 Paris Climate Agreement, there are concerns about its environmental impact and the need for further action to address climate change. And yet, a December 2023 study released during COP28 revealed that 91% of biotech and pharmaceutical companies do not have carbon reduction targets aligned with the Paris Agreement. Facing increasing regulatory pressures, a growing consumer demand for transparency, and the critical urgency to combat climate change, pharmaceutical organisations are seeking innovative solutions to embed sustainability into their core operations. One of the pivotal challenges in this journey is the effective management of Scope 3 emissions. In this

January 16, 2024 Data integrity forms the bedrock of effective supply chain management. Ensuring the accuracy, integrity, and security of supplier data across various systems can be complex, especially when dealing with multiple suppliers and data sources. From supplier databases, to performance metrics and audit trail documentation, each piece of data must retain its integrity to facilitate informed decision-making, operational efficiency, and most importantly, ensure compliance at all times. In this article, discover what to look out for when implementing a cloud-based supply chain platform, and learn how it can play a pivotal role in safeguarding data integrity, foster secure supplier relationships through seamless integrations, and help mitigate compliance risks across the supply chain ecosystem. Ensure your cloud-based platform employs robust encryption protocols and stringent access controls to safeguard sensitive supplier data. The most common root causes for a pharma data breac

January 02, 2024 The importance of an efficient and synchronised supply chain cannot be overstated, from manufacturers to patients, it plays a pivotal role in ensuring timely access to life-saving medical resources. During the Logipharma US conference in Boston last November, a panel discussion shed light on some key strategies for synchronising the supply chain, emphasising the patient's welfare as the ultimate goal. Mastering Data Management and Visibility for Synchronisation A fundamental aspect of synchronising the healthcare supply chain is mastering data management. This includes providing a clear demand signal and ensuring inventory visibility for suppliers. By harnessing the power of data, manufacturers can optimise production and distribution processes. Timely and accurate data enable them to respond swiftly to changes in patient demand, thereby reducing shortages or overstock situations. When patients receive the right care at the right time, it's a win-win for everyone in th